Literature DB >> 330404

Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes.

P C Leijh, M T van den Barselaar, R van Furth.   

Abstract

The study of the phagocytosis and intracellular killing of Candida albicans by granulocytes and monocytes has been hampered by the budding and pseudomycelium formation of this yeast during a relatively short incubation period at 37 degrees C and by the similar density of candida cells and phagocytes, which makes differential centrifugation impossible. In the present study, C. albicans was used after 5 days of preculture at 30 degrees C, after which the number of candida cells remained constant during incubation at 37 degrees C for 90 min. On this basis, phagocytosis and intracellular killing were limited to a period of 60 min. Phagocytosis of C. albicans by granulocytes and monocytes was measured with a hemocytometer, the number of extracellular candida being a measure of the ingestion of these microorganisms. After 60 min, 96% of the candida cells were ingested by normal human granulocytes and monocytes. This process was dependent on the opsonin concentration and temperature and was inhibited by mono-iodoacetic acid. Heat-inactivated serum was less active than fresh serum, reflecting the role of complement factors with respect to opsonization. Intracellular killing was measured by a microbiological assay. After 60 min of incubation of phagocytes together with C. albicans and serum, human granulocytes and monocytes killed 58 and 50% of the ingested candida, respectively. This process was inhibited by phenylbutazone. Phagocytes from patients with chronic granulomatous disease showed impaired intracellular killing.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330404      PMCID: PMC421120          DOI: 10.1128/iai.17.2.313-318.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Human serum interactions with Candida albicans.

Authors:  R A Chilgren; R Hong; P G Quie
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

Review 2.  Effects of hyperosmolality on candidacidal activity of human neutrophil polymorphonuclear leukocytes and on clumping of Candida albicans by human serum.

Authors:  S Kernbaum
Journal:  Biomedicine       Date:  1976-05

3.  Influence of therapeutic concentrations of phenylbutazone on granulocyte function.

Authors:  C O Solberg
Journal:  Acta Pathol Microbiol Scand B       Date:  1975-04

4.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

5.  A chromium release assay for phagocytic killing of Candida albicans.

Authors:  M Yamamura; J Boler; H Valdimarsson
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

6.  Assessment of phagocytic and antimicrobial activity of human granulocytes.

Authors:  L Schmid; K Brune
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

7.  Measurement of candidacidal activity of specific leukocyte types in mixed cell populations I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils.

Authors:  R I Lehrer
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

  7 in total
  40 in total

1.  Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes.

Authors:  E Martin; S Bhakdi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.

Authors:  A Komiyama; M Ichikawa; H Kanda; K Aoyama; K Yasui; M Yamazaki; H Kawai; Y Miyagawa; T Akabane
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

3.  The role of complement and antibody in opsonization and intracellular killing of Candida albicans.

Authors:  H A Pereira; C S Hosking
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

5.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

6.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; M R Daha; R van Furth
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

Review 7.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

8.  Production of interleukin-1-like cytokine by cultured rat glomerular macrophages.

Authors:  F Mampaso; T Bricio; A Martin; A Molina
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

9.  Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages.

Authors:  E M Peterson; R A Calderone
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.

Authors:  Lin Lin; Ashraf S Ibrahim; Xin Xu; Joshua M Farber; Valentina Avanesian; Beverlie Baquir; Yue Fu; Samuel W French; John E Edwards; Brad Spellberg
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.